Background. Chronic kidney disease (CKD) phenotypes such as albuminuria measured by urinary albumin creatinine ratio (ACR), elevated serum creatinine (SrCr) and/or decreased creatinine clearance (CrCl) and glomerular filtration rate (eGFR) are major risk factors for renal and cardiovascular diseases. Epidemiological studies have reported that CKD phenotypes cluster in families suggesting a genetic predisposition. However, studies reporting chromosomal regions influencing CKD are very limited. Therefore, the purpose of this study is to identify susceptible chromosomal regions for CKD phenotypes in Mexican American families enrolled in the San Antonio Family Heart Study (SAFHS). Methods. We used the variance components decomposition approach (implemented in the software package SOLAR) to perform linkage analysis on 848 participants from 26 families. A total of 417 microsatellite markers were genotyped at an average interval of 10 cM spanning 22 autosomal chromosomes. Results. All phenotypes were measured by standard procedures. Mean ± SD values of ACR, SrCr, CrCl and eGFR were 0.06 ± 0.38, 0.85 ± 0.72 mg/dl, 129.85 ± 50.37 ml/min and 99.18 ± 25.69 ml/min/1.73 m 2 body surface area, respectively. All four CKD phenotypes exhibited significant heritabilities (P < 0.0001). A genome-wide scan showed linkage on chromosome 2p25 for SrCr, CrCl and eGFR. Significant linkage was also detected on chromosome 9q21 for eGFR [logarithm of the odds (LOD) score = 3.87, P = 0.00005] and SrCr (LOD score = 2.6, P = 0.00026). ACR revealed suggestive evidence for linkage to a region on chromosome 20q12 (LOD score = 2.93, P = 0.00020). 
Introduction
Chronic kidney disease (CKD) is becoming a major public health concern [1, 2] . It is associated with many systematic complications including renal and cardiovascular diseases (CVDs) [3] . CKD is a manifestation of a gradual but permanent loss of kidney function over time, eventually progressing to end-stage renal disease (ESRD) and requiring renal replacement therapy [4] . CKD can be assessed by several clinical indicators such as albuminuria measured by the urinary albumin creatinine ratio (ACR), elevated serum creatinine (SrCr) and/or decreased glomerular filtration rate (GFR) [3] . A number of genetic epidemiological studies have shown that the CKD indicators/phenotypes cluster in families enriched with diabetes and/or hypertension, suggesting that there is a genetic predisposition of these phenotypes [5, 6] . A genetic analysis of urinary ACR in Pima Indians with type 2 diabetes suggested an existence of a major gene effect with Mendelian inheritance [7, 8] . Genome-wide scan to identify susceptibility loci for urinary ACR revealed suggestive evidence for linkage on various chromosomes [9] [10] [11] [12] . Some studies have identified 7q susceptibility loci in scans employing DN phenotypes defined by albuminuria [12, 13] . Krolewski et al. analyzed albuminuria as a quantitative trait and discovered a linkage peak at 7q36.2, which yielded a logarithm of the odds (LOD) score in excess of 3.0 [12] .
Genetic analysis conducted with creatinine clearance (CrCl) and estimated GFR (eGFR) have demonstrated that they are highly heritable [14] [15] [16] [17] [18] . Hunt et al. reported heritabilities of 0.33, 0.36 and 0.53 for three successive CrCl examinations in a healthy Utah pedigree [19] . DeWan et al. calculated heritability of CrCl as 0.17 in African Americans and 0.18 in non-Hispanic White hypertensive cohorts [20] . In regard to eGFR, using the Framingham Heart Study, Fox et al. determined that the eGFR heritability was 0.36 [21] . In a study of type 2 diabetic non-Hispanic White subjects, Langefeld et al. calculated the heritability of eGFR, using the MDRD (Modification of Diet in Renal Disease Study) equation, to be 0.75 after adjusting for age, gender, blood pressure, medications and haemoglobin A1c (HbA1c) levels [22] . Furthermore, in families with hypertension, Bochud et al. estimated the heritability of 0.52 for CrCl, estimated using the Cockcroft-Gault formula [23] . More recently, the Joslin group demonstrated significant eGFR heritability (h 2 = 0.45) in families enriched for T2DM [24] .
Many of these heritability studies simultaneously performed linkage analysis to identify chromosomal regions affecting regulation of quantitative CrCl and eGFR phenotypes. In the HyperGEN study involving 1100 hypertensive non-Hispanic White and African American subjects, a locus on 3q27 was identified [20] . Follow-up studies by this same group, with added subjects and denser genotyping, revealed linkage to 3p [25] and 7q [26] in the African American cohort. In two studies by Hunt et al., which examined pedigrees from non-Hispanic White families in Utah, loci on chromosomes 2q21.3 [14] and 10q23.3 [20] were identified for CKD phenotypes. The Framingham Heart Study identified linkage on chromosomes 3q26.3 with CrCl and on 4q23.3 with eGFR [21] . Altogether, these data indicate that CKD phenotypes are heritable in families enriched with diabetes, hypertension or both in African Americans, non-Hispanic White and Native Americans. However, the genetic influence on variation in CKD phenotypes in Mexican American families drawn from a community-based sample remains uninvestigated. The San Antonio Family Heart Study (SAFHS) aims to identify genes influencing the risk of CVD among low-income Mexican American families. This paper presents the first genome scan for localizing susceptible chromosomal regions for CKD phenotypes (ACR, SrCr, CrCl, eGFR) in families enrolled in SAFHS.
Methods

Population characteristics
The SAFHS is the first population-based project aimed to identify genes influencing the risk of CVD among Mexican American families. Probands for the SAFHS were selected randomly from a census tract in San Antonio of low-income Mexican Americans regardless of any preexisting medical conditions. Probands who were 40-60 years of age, had a spouse who was willing to participate and had at least six offspring who were ≥16 years of age were recruited. Family members including all first-, second-and third-degree relatives of probands ≥16 years of age and their spouse were invited to participate. Information regarding medical history, sociodemographics and anthropometrics was obtained in the first phase of SAFHS data collection [27, 28] .
Institutional review board from the University of Health Science Center at San Antonio approved the study and informed consent was taken from all participants.
Clinical variables CKD measures and calculations
In this study, a total of 848 individuals were phenotyped for serum levels of creatinine, and urinary albumin and creatinine. Single-void morning urine sample was collected from each participant. Albumin in urine was quantitatively determined by turbidimetric method (Beckman Synchron LX 20, Beckman Coulter, Inc., Fullerton, CA, USA). Urine creatinine was measured using the modified kinetic Jaffé method [29] . Urinary microalbumin was indexed to urinary creatinine as the urinary urine ACR in order to account for differences in urine concentration. Urinary ACR is a validated, reliable single-sample measure of urinary albumin excretion that is highly correlated with albumin excretion rates assessed by 24-h urine collection [30, 31] . Blood samples were collected from all participants after an overnight fast and plasma was prepared and stored at −80
• C until analyzed.
SrCr was estimated by the modified kinetic Jaffe reaction (Beckman Synchron LX System). Creatinine clearance (CrCl) was estimated using the Cockcroft- 
Genotyping
Genomic DNA was prepared from the lymphocytes of all enrolled subjects [32] . All family members were genotyped for 417 microsatellite markers that were spaced at an average interval of 10 cM. In addition, polymorphic markers in candidate genes were also included in the map as described previously by Comuzzie et al. [33] . The screening set and genotyping protocols are available at the website of the Center for Medical Genetics, Marshfield Medical Research Foundation (http://research.marshfieldclinic.org/genetics). After completion of the genotyping for the 10 cM marker map, the data were searched for spurious double recombination and those that were reflected by a high posterior probability of genotyping error were corrected. This correction significantly reduced the map expansion and led to the calculation of more accurate multipoint identity by descent (IBD) probabilities.
Quantitative genetic analyses
A multipoint linkage analysis was employed to detect a quantitative trait locus (QTL) or loci (QTLs) that might influence the variation in phenotypes related to CKD such as ACR, SrCr, CrCl and GFR. This technique is implemented in the software package SOLAR [34] . It is an extension of the variance components approach in which variance due to a specific QTL is added to the basic model. It is based on estimating the effect of a specific QTL on the variation in phenotype and can be modelled as a function of the IBD relationship at the marker locus between family members. The phenotypic correlations between family members can be described as the cumulative effect of a specific QTL associated with a marker, and residual genetic and environmental effects [35] . A model under the null hypothesis in which the additive genetic variance for a specific QTL equals zero was tested against a model under an alternate hypothesis in which the additive variance was estimated. This is known as a likelihood ratio test (LRT), and the resultant LRT statistic in this particular case was distributed asymptotically as a 1 2 : 1 2 mixture of a χ 2 variable with one degree of freedom and a point mass at zero [36] . Traditionally, a LOD score, which is computed directly from the LRT, is reported in linkage analyses. A LOD score of 3 implies that the probability that a QTL on a certain chromosome is affecting the variation in the trait of interest is 1000:1 and is considered to be significant, and a LOD score >2 (probability of linkage is 100:1) is considered as evidence of suggestive linkage [34] .
Results
This study was conducted with 848 participants (men = 313, women = 535) for whom we have both the genotypic and CKD phenotypic data. Relative pairs used for this study are listed in Table 1 . Relative pairs included in this study varied according to the trait being analyzed. A total of 6422, 7111, 6275 and 7004 pairs were used in the analysis of urinary ACR, SrCr, CrCl and eGFR, respectively. These included pairs such as parent-offspring, siblings, first cousins, second cousins, etc. The mean age of participants was 47.8 (SD ± 14.8) years and their BMI was 31.7 (SD ± 7.1) kg/m 2 . Mean values for urinary ACR, SrCr, CrCl and eGFR were 0.06 ± 0.38, 0.85 ± 0.72 mg/dl, 129.85 ± 50.37 ml/min and 99.18 ± 25.69 ml/min/1.73 m 2 body surface area, respectively. Of the CKD phenotypes, only SrCr was significantly different between sexes with men having higher levels of SrCr than women (P < 0.001). Our findings showed a relationship between ACR, CrCl and eGFR in diabetic and hypertensive subjects ( Table 2 ). The P-value for Table 2 was obtained from t-statistic which was computed from Student's t-test. This t-test was used to compare the phenotypic values between men and women. Of the study participants 37% were males, 52% hypertensives, 22% diabetics and ∼14% had albuminuria (Table 3) . We conducted quantitative genetic analysis of CKD phenotypes (ACR, SrCr, CrCl and eGFR) to determine genetic influence on their variation. Analysis showed all the above-mentioned phenotypes to be significantly heritable, as shown in Table 2 . Heritabilities obtained in this study (27) All values are presented as mean (standard deviation). # P < 0.05. $ P < 0.001. ACR: albumin creatinine ratio; SrCr: serum creatinine (mg/dl); CrCl: creatinine clearance (ml/min); eGFR: estimated glomerular filtration rate (eGFR, ml/min/1.73 m 2 body surface area). for CKD phenotypes were moderate and ranged between 0.19 and 0.25 (P < 0.001). The best model for the genomewide scan for these phenotypes was obtained with age, sex, their higher terms and interactions, BMI, blood pressure medication and diabetic duration as covariates. Using this model, we subsequently performed multipoint linkage analysis to localize the chromosomal region(s) influencing these quantitative traits of CKD. Linkage mapping for urine ACR showed five distinct genetic locations that did not overlap with the remaining CKD phenotypes. These regions exhibited a LOD score >1 on chromosomes 1, 13, 14, 17 and 20 ( Table 4 ). The highest linkage signal was on chromosome 20 near the marker D20S107 (Figure 1 ). Chromosomal regions associated with SrCr were 2, 5, 6, 7, 9 and 15 ( Table 4 ). The P-value for Table 4 (linkages) was calculated from a chi-square statistic usually used to test for variances. The chi-square statistic was computed from the difference between the null model and the test model. Of these, signals on chromosomes 6, 9 and 15 showed evidence of suggestive linkage (LOD > 2), whereas the highest signal was on chromosome 9 (LOD = 2.61, near marker the D9S922) (Figure 2) . Similarly, chromosomal regions on 2, 4, 10, 12, and 13 were associated with CrCl (Table 4) . Of these, the highest signal was found to occur at the marker D2S1780 on chromosome 2 ( Figure 3) . A strong signal was obtained for eGFR on chromosome 9 (Figure 1b ; LOD = 3.87, near the marker D9S1122) whereas other signals with LOD > 1 were localized to chromosomes 2, 4, 8 and 15 (Table 4). QTL on chromosome 2 (near the marker D2S1780) was common to SrCr, CrCl and eGFR. Regions on chromosomes 2, 9 and 15 were common for both SrCr and eGFR; in fact their highest signals were just 3 cM apart (Table 4) . Several positional candidate genes exist within the 1-LOD support interval for signals for the examined CKD phenotypes. The 1-LOD support interval is a standardized approach and is equivalent to a 95% confidence interval under the appropriate settings. The 1-LOD change corresponds to a change in the chi-square statistic of 4.6 with 1 df and a significance value of 0.04. To increase our chances in covering a larger interval, we extend the search to include the 1-LOD support interval before and after the threshold of the linkage peak [34, 36] . Table 5 depicts the 1-LOD support interval for QTLs for these phenotypes and genes that are present within this interval. The 1-LOD support intervals for urinary ACR and CrCl were 27 cM and 22 cM, respectively. SrCr and eGFR had overlapping 1-LOD support intervals of 13 cM each (Table 5) .
Discussion
In the current report, all the four examined CKD (ACR, SrCl, CrCl and eGFR) phenotypes were significantly heritable and showed evidence of linkage on various chromosomal locations. Heritability is a measure of trait-sharing among relatives due to inherited factors and ranges between 0 and 1 [37] . Studies estimating heritabilities for urine ACR and eGFR found them to be in the range of 0.3-0.44, which is similar to what we found in our study. Even though our heritabilities are relatively moderate, we were able to reject the null hypothesis of no genetic effect on the variation in CKD phenotypes (P < 0.05). Additionally, we found several major chromosomal regions; the most prominent at 2p25, 20q12 and 9q21 were significant contributors to CKD phenotypes among low-income Mexican American families enrolled in the SAFHS.
Albuminuria as estimated by urinary ACR was present in ∼14% of the participants. It is a major risk factor for renal as well as CVDs. We had previously conducted the genomewide scan with a smaller study sample and had a significant linkage of 3.5 on chromosome 20 (20q12) [38] . In this study sample, the addition of more individuals resulted in a decrease of the LOD score to 2.9 (P < 0.001), although the linkage remained in the same region. Replication of the linkage result shows that this region is of considerable importance with respect to albuminuria in this population.
Previous studies reporting genome-wide scans for urinary ACR have identified loci on chromosomes 5q, 7, 8, 16, 17, 18, 19 and 22q [12, 13, 16, 26, 39] . However, none of these studies have identified urinary ACR in the same region as ours. The difference in results might be due to differences in ascertainment methods, sample size and study designs. There are some interesting candidate genes in the 1-LOD support interval for this signal. Hepatic nuclear factor 4 alpha (HNF4alpha) is one among them, whose mutations have been associated with maturity onset diabetes of the young, type 1 (MODY 1) [40] . In Caucasian patients with T2DM, a single-nucleotide polymorphism in the promoter region of HNF4alpha was found to co-segregate with diabetes as well as renal target organ damage [41] . Other relevant candidate genes in this region are protein tyrosine phosphatase-1B (PTP-1B) [42] , protein kinase inhibitor gamma (PKIG) [43] and phospholipase C, gamma1 (PLCG1) [44] .
In our study, genome-wide scans for SrCr and eGFR identified QTLs for both of them in the same chromosomal region (9q21). Genetic studies exploring genomic loci regulating variation in GFR and SrCr have shown significant linkage on chromosomes 2, 3, 4, 7, 10, 14 and 19 [14, 16, 17, 26] . In a study conducted in Pima Indian sibling pairs, 9q22 was associated with diabetic nephropathy [13, 45] . The genes of potential interest in the region of 9q21-22 are Cathespin L (CTSL), implicated in the renal tubular response to proteinuria and myocardial ischaemia [46] , proprotein convertase 5 (PC5), which is colocalized with alpha V-integrin in atherosclerotic plaques and thus may have a role in inflammation or be associated with inflammation-related phenotypes [47] and transient receptor potential (TRP) cation channel, subfamily M, member 3 (TRPM3), a member of TRP family, which has a role in volume-regulated activity and renal calcium homeostasis [48] . Mutations in one of the TRP family members, TRPC6, have been implicated in focal segmental glomerulosclerosis [49] . ACR: albumin creatinine ratio; SrCr: serum creatinine (mg/dl); CrCl: creatinine clearance (ml/min); eGFR: estimated glomerular filtration rate (eGFR, ml/min/1.73 m 2 body surface area).
In this study, we found CrCl to be under significant genetic influence and obtained evidence for a suggestive linkage on chromosome 2 (2p25). This region harbours Kruppel-like factor 11 (KLF11) whose mutations tend to cause MODY type 7. The chromosomal region on chromosome 2 was consistent with all three phenotypes (same marker D2S1780) and similarly QTLs on chromosomes 9 and 15 were common for SrCr and eGFR. Altogether, the above results suggest a common genetic link between CrCl, SrCr and eGFR. This finding is expected since all the three phenotypes include SrCr as an important variable in their assessment. Interestingly, urinary ACR revealed distinct chromosomal regions as compared to SrCr, CrCl and eGFR. We speculate that urinary ACR and the remaining CKD phenotype may be regulated by different genes.
In this study, we found that the genes in the 1-LOD support interval surrounding the identified QTLs or the QTLs by themselves were related to CVD risk. For example, QTLs identified in this study on 2p25 and 20q12 were also associated with essential hypertension [50, 51] . A product of the gene prostacyclin synthase (PTGIS) in the region of 20q12-13, prostaglandin I2 is a vasodilator and inhibitor of platelet aggregation [52] . Nakayama et al. [53] found an association between exon 9 deletion in this gene and essential hypertension. Similarly, a gene in the region of 9q22-31, ATP-binding cassette, subfamily A, member 1 (ABCA1) has an important function as a cholesterol efflux pump in the cellular lipid removal pathway. Mutations in the ABCA1 gene have been associated with very low levels of HDL cholesterol and excessive tissue deposition of cholesterol esters [54] . Thus, regions around QTLs for CKD phenotypes 2p25, 20q12 and 9q21 harbour genes that confer risk for CVD.
Of the very few whole-genome scans conducted for CKD, there is some overlap between chromosomal regions identified in this study and reported by others. Puppala et al. [55] analyzed data from a Mexican American population that was at high risk for T2DM and its complications, to examine the genetic determinants of eGFR and determine the genotype by diabetes interaction influences on variation in eGFR. They found that the phenotypes GFR using the Cockcroft-Gault equation and GFR using the MDRD equation are significantly heritable (h 2 = 40% and 36%, respectively) in the Mexican-American population. Additionally, a strong evidence for linkage of eGFR was mapped to a genetic location on chromosome 9q in between the markers D9S922 (80 cM, 9q21.31) and D9S1120 (89 cM, 9q21.33). Interestingly, we identified similar linkage of eGFR to chromosome 9q (D9S1120). We speculate that unique eGFR alleles for the Mexican Americans cluster within these loci. Fine mapping of the 9q21 region would allow identification of common genetic determinants influencing eGFR in Mexican Americans.
In contrast, our findings did not overlap with the first scan by Hunt et al. who identified linkage of CrCl to chromosome 10q in families from Utah, which were ascertained for CVD risk with a relatively normal GFR [19] . Also, our findings did not overlap with results from the second scan done by the same group, which reported an evidence for linkage of GFR to chromosome 2q [14] [21] . CrCl was estimated using the Cockcroft-Gault equation and eGFR was estimated using the simplified MDRD equation. The peak LOD scores for SrCr, eGFR and CrCl were 2.28 at 176 cM on chromosome 4, 2.19 at 78 cM on chromosome 4 and 1.91 at 103 cM on chromosome 3, respectively. Recently, Placha et al. reported a genome scan of eGFR estimated by serum cystatin C, and MDRD and Cockroft-Gault equations, in 63 extended Caucasian pedigrees (406 individuals with T2DM, 428 without diabetes) with normal eGFR values [24] . This group detected evidence for linkage among diabetic relatives on chromosome 2q and suggestive evidence on 10q, in proximity to the region previously identified by Hunt et al. [19] , and 18p. Despite the similarities in phenotype definitions in these studies, linkage peaks identified in the current study are contradictory to the previous findings owing to differences in ethnic composition of the populations studied and/or study designs.
A potential limitation of this study is that some quantitative measures such as urinary ACR and eGFR were determined on the basis of a solo random collection. Although validation with sequential measures would be an ideal approach, yet quality control studies demonstrated negligible variability on repeated creatinine measurements of the same serum sample (personal communication; Parekh et al., unpublished data). Further future studies will be performed and statistically analyzed in the genome-wide linkage approach to confirm our findings.
In conclusion, several linkage peaks for the phenotypes of CKD were identified in a Mexican American cohort (SAFHS). After adjustment for diabetes duration and hypertension medication, the peaks on chromosomes 2, 9 and 20 were significant for linkage strongly suggesting that unique CKD alleles cluster within these loci. Fine mapping of these regions would eventually identify the genetic variants responsible for the linkage. Additional investigations examining the association of CKD and genetic loci in large populations are justified to verify our conclusions.
